|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0002092,
umls-concept:C0004096,
umls-concept:C0030685,
umls-concept:C0032952,
umls-concept:C0079189,
umls-concept:C0127400,
umls-concept:C0178539,
umls-concept:C0205122,
umls-concept:C0391871,
umls-concept:C0680255,
umls-concept:C0681850,
umls-concept:C0805586,
umls-concept:C0871261,
umls-concept:C1280500,
umls-concept:C1283071,
umls-concept:C1363844,
umls-concept:C1550501,
umls-concept:C1704632,
umls-concept:C1706203,
umls-concept:C1706817,
umls-concept:C1963578,
umls-concept:C2349001,
umls-concept:C2697811,
umls-concept:C2911692
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2001-7-11
|
|
pubmed:abstractText |
Systemic glucocorticoids are a major therapy for the management of allergic inflammation and asthma; however, information about their effects in vivo are limited.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0091-6749
|
|
pubmed:author |
pubmed-author:BochnerB SBS,
pubmed-author:BreslinLL,
pubmed-author:FreidhoffL RLR,
pubmed-author:HubbardW CWC,
pubmed-author:LichtensteinL MLM,
pubmed-author:LiuM CMC,
pubmed-author:ProudDD,
pubmed-author:SchleimerR PRP,
pubmed-author:SchroederJ TJT,
pubmed-author:StealeyB ABA,
pubmed-author:XiaoHH
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
108
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
29-38
|
|
pubmed:dateRevised |
2007-11-14
|
|
pubmed:meshHeading |
pubmed-meshheading:11447379-Adult,
pubmed-meshheading:11447379-Allergens,
pubmed-meshheading:11447379-Anti-Inflammatory Agents,
pubmed-meshheading:11447379-Asthma,
pubmed-meshheading:11447379-Bronchoalveolar Lavage Fluid,
pubmed-meshheading:11447379-Cross-Over Studies,
pubmed-meshheading:11447379-Cytokines,
pubmed-meshheading:11447379-Double-Blind Method,
pubmed-meshheading:11447379-E-Selectin,
pubmed-meshheading:11447379-Eicosanoids,
pubmed-meshheading:11447379-Female,
pubmed-meshheading:11447379-Forced Expiratory Volume,
pubmed-meshheading:11447379-Glucocorticoids,
pubmed-meshheading:11447379-Histamine Release,
pubmed-meshheading:11447379-Humans,
pubmed-meshheading:11447379-Leukocyte Count,
pubmed-meshheading:11447379-Male,
pubmed-meshheading:11447379-Prednisone,
pubmed-meshheading:11447379-RNA, Messenger
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Effects of prednisone on the cellular responses and release of cytokines and mediators after segmental allergen challenge of asthmatic subjects.
|
|
pubmed:affiliation |
Johns Hopkins University School of Medicine at the Johns Hopkins Asthma and Allergy Center, Baltimore, MD 21224-6801, USA.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, U.S. Gov't, P.H.S.,
Randomized Controlled Trial
|
